Abstract

MotivationCirculating tumor cells (CTCs) are widely studied using liquid biopsy methods that analyze fractionally-small peripheral blood (PB) samples. However, little is known about natural fluctuations in CTC numbers that may occur over short timescales in vivo, and how these may affect detection and enumeration of rare CTCs from small blood samples.MethodsWe recently developed an optical instrument called “diffuse in vivo flow cytometry” (DiFC) that uniquely allows continuous, non-invasive counting of rare, green fluorescent protein expressing CTCs in large blood vessels in mice. Here, we used DiFC to study short-term changes in CTC numbers in multiple myeloma and Lewis lung carcinoma xenograft models. We analyzed CTC detections in over 100 h of DiFC data, and considered intervals corresponding to approximately 1%, 5%, 10%, and 20% of the PB volume. In addition, we analyzed changes in CTC numbers over 24 h (diurnal) periods.ResultsFor rare CTCs (fewer than 1 CTC per ml of blood), the use of short DiFC intervals (corresponding to small PB samples) frequently resulted in no detections. For more abundant CTCs, CTC numbers frequently varied by an order of magnitude or more over the time-scales considered. This variance in CTC detections far exceeded that expected by Poisson statistics or by instrument variability. Rather, the data were consistent with significant changes in mean numbers of CTCs on the timescales of minutes and hours.ConclusionsThe observed temporal changes can be explained by known properties of CTCs, namely, the continuous shedding of CTCs from tumors and the short half-life of CTCs in blood. It follows that the number of cells in a blood sample are strongly impacted by the timing of the draw. The issue is likely to be compounded for multicellular CTC clusters or specific CTC subtypes, which are even more rare than single CTCs. However, we show that enumeration can in principle be improved by averaging multiple samples, analysis of larger volumes, or development of methods for enumeration of CTCs directly in vivo.

Highlights

  • Circulating tumor cells (CTCs) are of great interest in cancer research because of their importance in hematogenous metastasis

  • We showed that diffuse in vivo flow cytometry” (DiFC) permitted longitudinal study of CTCs and CTC multi-cellular clusters (CTCCs) in individual mice at burdens below 1 CTC per ml of peripheral blood (PB)

  • CTC numbers were far from steady state, and exhibited variability far exceeding that expected by Poisson statistics or DiFC operator variability

Read more

Summary

Introduction

Circulating tumor cells (CTCs) are of great interest in cancer research because of their importance in hematogenous metastasis. CTCs shed from the primary tumor into the peripheral blood (PB), and a small fraction may form metastases. It is these metastases that are extremely difficult to control clinically and eventually result in the majority of cancer-related deaths [1, 2]. Most CTC clinical and pre-clinical research involves “liquid biopsy”, wherein CTCs are isolated from fractionally small PB samples [3, 4]. There have been a number of large clinical studies in the last decade, the clinical value of CTC enumeration by liquid biopsy remains as yet unclear [8,9,10]. One major challenge is CTC heterogeneity, which has driven major efforts toward development next-generation liquid biopsy methods that permit genotypic and phenotypic characterization of single CTCs [11, 12]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call